Location: Home
  • search
  • go
  • Relate News
  • 8/6/2021Recent Executive Moves
  • 8/6/2021NHC Releases 2020 Annual Health Sector Development Report (Full Summa...
  • 8/5/2021CDE Issues on the Technical Guidelines for Clinical Trials for ANVUGIB...
  • 8/5/2021Hanmi Pharma and Lego Chem Bio Enter Partnership Deal to Co-develop AD...
  • 8/5/2021Everest Med Granted Chinese CTA for Phase 3 Trial of Xerava for CABP
  • 8/5/2021Roche China and AnPac Bio Tie Up for Innovative Healthcare and Medic...
  • 8/5/2021Promega and Henlius Developing MSI Companion Diagnostic IVD Kit for Se...
  • 8/5/2021Schrödinger and Zai Lab Announce a Global R&D Collaboration in Oncolo...
  • 8/5/2021China Reports Steady IP Growth In H1 with Foreign Firms Filing More Pa...
  • 8/5/2021Review of China Healthcare Sector Performance in H1/2021
  • 8/5/2021Forbes: Bayer Sees A Golden Age For China's Pharmaceutical Market
  • 8/5/2021CNIPA Solicits Comments On Revisions To CN Patent Exam Guidelines
  • 8/5/2021China Is Poised To Enter The Global Injectable Market – An Expert CDM...
  • 8/5/2021PharmaDJ: ADCs are on the Rise in China
  • 8/5/2021Santen Pharma Set to Expand in China with More Investment
  • 8/4/2021NMPA Reportedly Seeking Comments on Proposed Regulation of Online Drug...
  • 8/3/2021CStone Announces Positive Clinical Results and NDA of Ivosidenib in ...
  • 8/3/2021Burning Rock and IMPACT Therapeutics Announce a Global Partnership for...
  • 8/3/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (47...
  • 8/3/2021CDE Solicits Comments on the Technical Guidelines for Expansion Cohort...
  • 8/3/2021WuXi STA Completes Acquisition of BMS Manufacturing Facility in Couvet...
  • 8/3/2021India Initiates Anti-dumping Probe against Chemical from China for Ato...
  • 8/3/2021BeiGene Announces Plans to Build New Manufacturing and Clinical R&D Ce...
  • 8/3/2021111, Inc. Enters into Strategic Deal with Zelgen for a New iver Cancer...
  • 8/3/2021"Unofficial" Chinese Orange Book User Guide For Pharmaceutical Patents
  • 8/3/2021Bribery in China: Hospital Purchases Pose A FCPA Concern for Healthcar...
  • 8/3/2021PharmaDJ: June Numbers Spike with a Big In-Licensing Deal
  • 8/2/2021The Exponential Growth Potential of Asia's Pharmaceutical Markets
  • 8/2/2021Chinese Biosimilars Surge between 2018 and 2020 Due to New NMPA Regula...
  • 8/2/2021Biopharma Companies Still Waiting for Clarity on China's New Patent Te...
  • Page:198/797 Total number of articles:23898: [First][<<] [196] [197] [198] [199] [200] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group